Acthrel (Ferring Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Acthrel drug offered from Ferring Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ferring Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Corticorelin ovine triflutate
SUBSTANCE NAME: CORTICORELIN OVINE TRIFLUTATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-05-23
END MARKETING DATE: 0000-00-00


Acthrel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionActhrel from Ferring Pharmaceuticals Inc.
LABELER NAME: Ferring Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(ug/2mL)
START MARKETING DATE: 1996-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55566-0302_4698848e-3251-49f8-bcac-614fd485c784
PRODUCT NDC: 55566-0302
APPLICATION NUMBER: NDA020162

Other CORTICORELIN OVINE TRIFLUTATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ferring Pharmaceuticals Inc.Acthrel